LIFEVANTAGE CORP Form CORRESP: Company correspondence with SEC staff
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-18: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2023-04-04: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2020-04-01: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2013-09-27: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-18 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-04-04 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-04-01 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2013-09-27 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2007-01-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2006-10-17 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2006-07-20 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2006-07-13 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2006-03-22 | CORRESP | Company correspondence with SEC staff | filename1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |